ArticleCancers2026

Efficacy and Safety of Oral NEPA Versus Fosaprepitant Plus Palonosetron for Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Nasopharyngeal Carcinoma: A Propensity-Score-Matched Retrospective Study.

Yilin Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.